Jointly provided by Global Education Group and Consultants in Medical Education (CiME)
This activity is supported by an independent educational grant from Stallergenes Greer.
Allergic rhinitis (AR) affects an estimated 1 in 6 Americans, a significant proportion of whom are sensitized against at least one of the five major grass species in the US. Patients with grass-pollen induced AR face a lifelong journey of seasonal symptom control without effective disease modification. Increasing understanding of the process of developing tolerance to specific grass pollen aeroallergens has resulted in the development of allergen immunotherapies that have the potential to alter disease course and provide significantly improved quality of life for patients with AR. This patient case activity will guide clinicians through the process of clinical history-taking, specific allergen testing, and discuss management plans that use complete patient sensitization profiles to direct both symptomatic control and disease modification of AR. This activity aims to increase learner competence at differentially diagnosing AR, designing effective symptom control plans, and working with patients to implement long-term disease modification via different allergen immunotherapy approaches.
The educational design of this activity addresses the needs of allergists, otolaryngologists, immunologists and other health care professionals involved in the treatment of patients with grass-pollen induced allergic rhinitis
After completing this activity, the participant will demonstrate the ability to:
Conduct a complete patient interview and exam to establish history, triggers, lung health and a clinical diagnosis of allergic rhinitis
Perform allergy testing to establish a definitive trigger in patients with a clinical diagnosis of allergic rhinitis
Discuss evidence-based treatment approaches for patients who are mono- or polysensitized versus allergic to grasses and other allergens
Compare subcutaneous versus sublingual immunotherapy in terms of efficacy, safety, rates of systemic reactions and a patient’s ability to adhere to the treatment course
Disclosure of Conflicts of Interest
Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
Deborah A. Gentile, MD Adjunct Professor of Medicine; Drexel University School of Medicine Director of Allergy/Asthma Research; Division of Pulmonary, Allergy and Critical Care Medicine; Allegheny Health Network Pittsburgh, PA
Dr. Gentile reported a financial relationship with Stallergenes Greer.
Peter Socrates Creticos, MD Associate Professor of Medicine, Johns Hopkins School of Medicine – Division of Allergy & Clinical Immunology Director of Clinical Research, Creticos Research Group, LLC Baltimore, MD
Dr. Creticos reported financial relationships with Stallergenes Greer, Circassia, Allakos, Inc., Anergis SA, Merck & Co., Inc., and WebMD LLC (Medscape).
Ayesha N. Khalid, MD, MBA Cambridge Health Alliance; Clinical Instructor, Harvard Medical School Concord, MA
Dr. Khalid reported financial relationships with 480 Biomedical, Castle Creek Pharma, Stallergenes Greer, Patient Doctor Technologies, Inc. (Doctella), Abbott, Lungpacer Medical Inc.
Accredited Provider Disclosure
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Ashely Marostica, RN, MSN, has nothing to disclose to report in regards to financial relationships. Andrea Funk has nothing to disclose to report in regards to financial relationships. Laura Gilsdorf has nothing to disclose to report in regards to financial relationships. Chris Blagden, PhD, has nothing to disclose to report in regards to financial relationships.
AMA PRA Category 1 Credit(s)TM
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and CiME. Global is accredited by the ACCME to provide continuing medical education for physicians.
Global Education Group designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 CreditTM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and CiME do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
There is no fee for this activity. In order to receive credit, users must:
Read the learning objectives and faculty disclosures.
Participate in the activity.
Complete the post-test. Participants will have 2 tries to achieve a passing score of 80% or higher.
Complete the activity evaluation.
Upon successful completion of this program, a statement of credit will be available to print from your CME History on myCME (located under My Account), which can be accessed at any time.
Global protects the privacy of personal and other information regarding participants, educational partners and joint sponsors. Global and our joint sponsors will not release personally identifiable information to a third party without the customer's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.